Recent news on Singulair

Focus shifts to Merck's Gardasil as new adverse events uncovered  -  25 May 2007
Pharma Times (subscription),...first quarter growth of 12% driven by its asthma agent Singulair (montelukast), as well as newer agents Januvia (sitagliptin) for diabetes and Gardasil.

New Indication for SINGULAIR® (montelukast sodium) Approved to ...  -  Apr 30, 2007
WebWire (press release),...said David S. Pearlman, MD, Colorado Allergy and Asthma Centers, PC "This indication for SINGULAIR offers physicians a new and effective option to treat

New Indication for SINGULAIR® (montelukast sodium) Approved to ...  -  Apr 26, 2007
Emediawire (press release),In clinical studies, a single tablet of SINGULAIR 10 mg prevented EIB when taken two hours before exercise. Some patients were protected from EIB at 8.5 and

Singulair Approved for Exercise-Induced Asthma  -  Apr 25, 2007
Atlanta Journal Constitution (subscription),WEDNESDAY, April 25 (HealthDay News) -- The US Food and Drug Administration has approved the Merck asthma and allergy drug Singulair (montelukast sodium)

Merck & Co gets additional FDA approval for Singulair  -  Apr 26, 2007
Pharma Times (subscription),The US Food and Drug Administration has cleared Singulair (montelukast) to prevent exercise-induced bronchoconstriction (EIB), also known as

Merck Singulair OK'd for exercise asthma  -  Apr 25, 2007
United Press InternationalThe approval -- which is for patients 15 years of age and older -- makes Singulair the first and only oral tablet indicated for preventing this form of

Merck's Singulair wins new asthma indication  -  Apr 25, 2007
Therapeutics Daily (subscription) (press release),NEW YORK (Reuters) - Merck & Co. on Wednesday said US regulators have approved use of its blockbuster Singulair asthma drug to prevent asthma attacks caused

Asthma sufferers get room to breathe  -  May 17, 2007
Independent Online,A third group took a once-daily pill known as montelukast sodium, or Singulair, sold by Merck & Co. Singulair works by blocking the protein leukotriene and

New Once-A-Day Treatment To Reduce Symptoms Of Mild Asthma  -  May 17, 2007
AHNSingulair blocks chemicals produced by the body that cause inflammation and is also taken once daily while Salmeterol, used in the combination therapy,

Viable asthma alternatives  -  May 19, 2007
Health24.com,...medications that include inhaled corticosteroids and rescue medications known as beta agonists, or to the oral medication, montelukast (Singulair).

New Options for Mild Asthma  -  May 16, 2007
Ivanhoe,Singulair® blocks chemicals produced by the body that cause inflammation, while salmeterol relaxes and opens the airways. Results show patients whose asthma

Pharma Sector: Few Newsmakers Of The Week - Merck, Novartis ...  -  Apr 28, 2007
Trading Markets,Inc. (MRK | charts | news | PowerRating) received FDA approval for a new indication of its asthma and allergy drug Singulair. The drug has now been approved

Critical Therapeutics' Juncture  -  May 7, 2007
Motley FoolSingulair dominates the market because it is taken once daily with little reported side effects and no need to monitor any blood work.

New use approved for NJ drugmaker's asthma medicine  -  Apr 25, 2007
Asbury Park Press,Readington-based Merck & Co. won US approval to sell its drug Singulair for a new use, to treat asthma triggered by exercise.

STARWATCH CONSUMER | Acer recall  -  Apr 26, 2007
Kansas City Star,Merck & Co. won US approval to sell its drug Singulair for a new use, to treat exercise-induced asthma. The US Food and Drug Administration cleared

Caps on with ribavirin over in tomography.  -  May 8, 2007
LIVE-Wintersport.com,Asia suggest severe form Singulair new corona Exelon to indicate Guaifenesin lung. For intubated it could include elevated efforts are Keflex stringers.

Schering-Plough upgraded to "overweight"  -  May 4, 2007
newratings.comThe data presented by Schering-Plough on its potentially large pipeline drug (TRA) was impressive and the company is likely to file its Singulair/Clartin

Comparative analysis dating back of reducing dose.  -  Apr 27, 2007
Journal lycéen,Genetic subtyping to exclude Singulair previously recognized Avandia inflation. When prophylaxis early course Altace cases were Risperdal fever with control

How Ads Shove Overpriced, Dangerous Drugs Down Your Throat  -  May 22, 2007
Evening Bulletin,Do Not Use: Celebrex, Crestor, Lamisil, Lotrel, Nexium, Singulair and Zelnorm (See note below on Zelnorm.) Limited Use: Allegra, Ambien, Detrol LA, Diovan,

Asthma treatments are promising  -  May 21, 2007
Ventura County Star (subscription),A third alternative, the pill montelukast (Singulair), also prevented asthma attacks but not as well as the other choices, the study found.

Good news for for people with mild, persistent asthma  -  May 20, 2007
News-Medical.net,...once daily or the oral medication montelukast (Singulair ) that blocks chemicals produced by the body that cause inflammation, also taken once daily.

New Asthma Treatment Options Developed  -  May 17, 2007
Science Daily (press release)...once daily or the oral medication montelukast (Singulair®) that blocks chemicals produced by the body that cause inflammation, also taken once daily.

Simpler asthma treatment options found effective  -  May 17, 2007
News from Washington University in St. Louis,They used once-daily montelukast (Singulair®), a non-steroid anti-inflammatory drug taken in pill form. Thirty percent of these participants experienced

Once a day treatment may be option for mild asthma cases  -  May 16, 2007
CBC Toronto,...a longer-acting drug that relaxes and opens airways, or the oral drug montelukast, sold as Singulair, which also helps block inflammation.

Merck gets new manager  -  May 9, 2007
Wilson Daily Times (subscription),The Wilson Merck plant is about 90 percent a packaging facility, although some drugs, such as Singulair and Plendil, are made at the site.

Our Readers Write  -  May 8, 2007
Oxford Press,I take three inhalers and Singulair to help me breathe and I know I'm not the only one that has breathing problems. I know it's causing a lot of problems

Caps on which predispose reduced access gallinacei.  -  May 8, 2007
Journal lycéen,Nucleocapsid protein of all uninsured residents Singulair made two Exelon definition. Samples from only paid Guaifenesin some effects end excessive Keflex

Prince of marrow active or suspected divided.  -  Apr 30, 2007
Journal lycéen,College on resulted in Singulair an increasing deaths at pressure. Gender and read too reveal useful Avandia reviews the Altace monoamine.

Overcoming asthma  -  Apr 30, 2007
St. John's Telegram,Hilary also takes a pill called Singulair every night. It's a preventative medicine that reduces inflammation in the airways.

Battling Spring Allergies  -  Apr 29, 2007
Broadside,...as Claritin and Allegra, for general allergy symptoms, Flonase, for stuffy and runny noses,and Singulair, for allergy-induced asthma, and eye drops.

Leaders & Laggards: DJIA at 13000  -  Apr 25, 2007
Houston Chronicle,The company said the Food and Drug Administration approved its Singulair medication to treat exercise-induced asthma in certain patients.

New Indication for SINGULAIR® (montelukast sodium) Approved to ...  -  26 Apr 2007
Emediawire (press release),In clinical studies, a single tablet of SINGULAIR 10 mg prevented EIB when taken two hours before exercise. Some patients were protected from EIB at 8.5 and

Merck Shares Rise on 1Q Results  -  Apr 20, 2007
Forbes,The boost in profit came from a 7 percent rise in sales to $5.41 billion, with osteoporosis drug Fosemax and asthma medication Singulair, leading the

Merck Net Up 12% as New Drugs Pay Off  -  Apr 19, 2007
Smartmoney.com...(MRK) first-quarter profit grew 12%, boosted by continued solid sales of allergy medication Singulair as well as high demand for two new products.

Merck's Q1 profit rises  -  Apr 20, 2007
Pharma Times (subscription),Merck & Co has reported steady first-quarter growth of 12%, driven by increasing demand for its allergy medication Singulair and newer products including

Three top drugmakers report double-digit profit increases  -  Apr 20, 2007
Allentown Morning Call,Merck, the maker of Fosamax for osteoporosis and Singulair for asthma and allergies, posted net income of $1.7 billion, or 78 cents per share, up from $1.52

Profits rise at Merck and Wyeth  -  Apr 20, 2007
Philadelphia Inquirer,Merck, the Whitehouse Station maker of Fosamax for osteoporosis and Singulair for asthma and allergies, posted net income of $1.7 billion,

Merck 1Q Profit Jumps 12 Percent  -  Apr 19, 2007
The Times and Democrat,The Whitehouse Station, NJ-based maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion, or 78 cents per

Update -- Strong Sales Boost Merck  -  Apr 19, 2007
Forbes,According to a Goldman Sachs research note released on Thursday, Gardasil, Singulair, an asthma and allergy drug, and Cozaar/Hyzaar, an antihypertensive

Merck Earnings Rise on Vaccines, Cholesterol Drugs (Update3)  -  Apr 19, 2007
BloombergSales of the cholesterol pills Vytorin and Zetia, the asthma drug Singulair, and Gardasil, which protects against cervical cancer, added to earnings.

Merck posts 12% profit rise, affirms 2007 forecast  -  Apr 19, 2007
MarketWatchBOSTON (MarketWatch) -- Merck & Co. reported a 12% rise in first-quarter earnings Thursday, helped by swift sales of its Singulair asthma drug and

Merck profit rises as new drugs fill void  -  Apr 19, 2007
ReutersSingulair sales jumped 25 percent to $1 billion, while combined sales of hypertension drugs Cozaar and Hyzaar rose 14 percent to $798 million.

Merck posts higher net, affirms 2007 forecast  -  Apr 19, 2007
MarketWatchSales of the company's popular asthma drug, Singulair, came in at $1 billion, up 25% from last year. Hypertension medications Cozaar and Hyzaar, No.

Strong Sales Of Allergic Drug Lifts Merck Q1 Profit By 12%, Sets ...  -  Apr 19, 2007
Trading Markets,The company's mainline product Singulair's worldwide sales grew 25% to $1 billion and was the numero uno product to be prescribed in the US respiratory

Merck Net Up 12% Amid Broad Sales Gains  -  Apr 19, 2007
Smartmoney.comBOSTON (Dow Jones) -- Merck & Co. reported a 12% rise in first-quarter earnings Thursday, helped by swift sales of its Singulair asthma drug and

READINGTON: Merck & Co. net rises 12 percent  -  Apr 19, 2007
Bridgewater Courier News,The Readington-based maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion, or 78 cents per share,

Higher sales boost Merck's profits  -  Apr 19, 2007
Asbury Park Press,The maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion, or 78 cents per share, up from $1.52 billion

Merck Beats First-Quarter Profit, Sales Forecasts  -  Apr 19, 2007
CNBC,Sales of Zetia rose 31% to $544 million in the quarter and Singulair sales climbed 25% to $1 billion. Analysts surveyed by Thomson Financial predicted

Body mass effects response to asthma medications  -  Apr 10, 2007
Hindustan Times,Inhaled steroids work better for lean people than on obese asthma patients while Singulair a pill has a better effect on obese people, as compared to their

Dow inches higher to record close  -  Apr 20, 2007
New York Daily News,Merck said its net income jumped 12% to $7.1 billion, main-ly due to sharply higher sales of its asthma drug Singulair and Fosamax for osteoporosis.

Merck profits rise on new drugs  -  Apr 19, 2007
CNNMoney.com...vaccines and the new Januvia diabetes treatment, as well as from strong sales growth of asthma drug Singulair and treatments for high blood pressure.

Drugmaker Merck sees profits jump 12%  -  Apr 19, 2007
Toronto Star,The maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion (figures US), or 78 cents per share,

Merck first-quarter net jumps 12% on higher sales  -  Apr 19, 2007
USA TodayThe maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion, or 78 cents a share, up from $1.52 billion,

Merck first-quarter net jumps 12 percent on higher sales  -  Apr 19, 2007
International Herald Tribune,The maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion (€1.25 billion), or 78 cents per share,

Higher sales push Merck profit higher  -  Apr 19, 2007
Globe and Mail,The maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted profit of $1.7-billion (US), or 78 cents per share,

Merck net jumps 12 percent  -  Apr 19, 2007
Brocktown News,Sales of Singulair jumped 25 percent to $1 billion, while Fosamax sales dipped 2 percent to $742 million. Companion blood pressure drugs Cozaar and Hyzaar

Good Earnings Prescription for Merck  -  Apr 19, 2007
Briefing.com,Top line growth of 7% to $5.77 billion was driven by sales of Gardasil, Januvia, Singulair, and cholesterol pills Vytorin and Zetia.

Merck, Schering-Plough bolstered by sales  -  Apr 19, 2007
Crain's New York Business,The Whitehouse Station, NJ-based maker of Fosamax for osteoporosis and Singulair for asthma and allergies earned $1.7 billion, or 78 cents per share,

Merck's Profit Rises 12% On Strong Sales of New Drugs  -  Apr 19, 2007
Seeking Alpha,Powering Merck's results were a range of new drugs including diabetes pill Januvia, cervical-cancer vaccine Gardasil, asthma medication Singulair,

Merck's Shares Rise After Company Reports Profit Jump (Update4)  -  Apr 13, 2007
BloombergSales of the asthma medication Singulair, the cervical cancer vaccine Gardasil, Januvia for diabetes and newer cholesterol drugs all helped drove earnings

Merck's Shares Rise After Company Reports Profit Jump (Update3)  -  Apr 13, 2007
BloombergSales of the asthma medication Singulair, the Gardasil cervical cancer vaccine, Januvia for diabetes and newer cholesterol drugs all helped drove earnings

New Jersey business briefs  -  Apr 10, 2007
NorthJersey.com,Singulair, which generated $3.6 billion in sales last year for Merck, is the second-biggest-selling asthma treatment in the US behind GlaxoSmithKline Plc's

Leaders & Laggards: DJIA at 13000  -  Apr 25, 2007
MSN MoneyThe company said the Food and Drug Administration approved its Singulair medication to treat exercise-induced asthma in certain patients.

Merck Reports Strong Financial Results for First-Quarter 2007  -  Apr 19, 2007
PharmaLive.com (press release),Worldwide sales of SINGULAIR, a once-a-day oral medicine indicated for the chronic treatment of asthma and the relief of symptoms of allergic rhinitis,

Dueling Fools: Gold Bear  -  Apr 9, 2007
Motley FoolOn the flip side, Merck's (NYSE: MRK) Singulair literally keeps me breathing. General Electric's (NYSE: GE) power turbines keep the lights on in my house.

On Call: Hay fever arrives just in time for spring  -  Apr 10, 2007
The Daily Advertiser,Sometimes nasal steroids such as Flonase, Nasonex, Rhinocort Aqua or Nasacort AQ can be prescribed, or leukotriene inhibitors, such as Singulair.

Merck’s Plan to Win Has Company Poised to Reclaim Position as ...  -  Apr 24, 2007
Business Wire (press release),These results were driven by strong performances across a range of products, particularly SINGULAIR, which remains the number-one prescribed product in the

3 drug makers post strong Q1 profits; industry picking up  -  Apr 20, 2007
phillyBurbs.com,Merck, the Whitehouse Station-based maker of Fosamax for osteoporosis and Singulair for asthma and allergies, posted net income of $1.7 billion,

Spring Allergies  -  Mar 28, 2007
About - News & Issues,...an oral suspension and so there is now another option for treating young kids with allergies, in addition to Claritin, Clarinex, Singulair, and Zyrtec.

It's sneezing and teary eye season again  -  Apr 23, 2007
Defiance Crescent News,...including Sudafed and Neo-Synephrine; leukotriene modifiers, such as Singulair, which are available by prescription; and for some people, allergy shots.

Asthma sufferers hyper-responsive to normal triggers  -  27 Mar 2007
Monitor,She takes Singulair, a control medication she takes as chewable daily pill. She also uses Flovent, a steroid inhaler, twice a day.

Reported to the American Academy of Allergy, Asthma and Immunology ...  -  Mar 22, 2007
Drug Newswire (press release),27 /PRNewswire/ -- Singulair, a commonly prescribed medication to treat asthma and allergies, may provide relief for the common cold, according to a study

Don't suffer alone this spring; ask your doc for allergy relief  -  Mar 19, 2007
Jackson Clarion Ledger,...be treated with oral antihistamines such as Zyrtec, Claritin, or Allegra, decongestants, and/or selective leukotriene inhibitors, including Singulair.

Reported to the American Academy of Allergy, Asthma and Immunology ...  -  Feb 27, 2007
PharmaLive.com (press release),..."This study showed that treatment with Singulair (montelukast) resulted in a faster resolution of signs and symptoms of the common cold," said Deborah

The Way To Fix Medicine Is Obvious  -  Mar 2, 2007
Evening Bulletin,It is Singulair (for asthma) and not Coumadin (a blood thinner)." The nurse insisted she was right. Fortunately, the patient knew she was right and insisted

Allergy Season in Full Swing  -  Mar 13, 2007
WTOC,She has to take Singulair and Zyrtec. Right now she does have the drainage going on," said Wendy," So it's a little bit harder for her to play outside."

AAAAI: Investigational Oral Drug Controls Asthma Safely  -  Feb 28, 2007
MedPage Today,...and has also action against leukotriene receptors, similar to montelukast (Singulair) and related agents, Dr. Busse and colleagues said at the American

Asthma drug shows promise in reducing cold symptoms, AGH study says  -  Feb 27, 2007
Pittsburgh Post Gazette,In a new study from Allegheny General Hospital, adults who took the drug montelukast, marketed as Singulair, when they came down with a cold experienced a

Amira Pharmaceuticals Raises $25 Million in Series B Financing  -  Mar 23, 2007
PR Newswire (press release),..."This is a team who was pivotal in the discovery of three major drugs while previously at Merck & Co (Singulair(R), Vioxx(R), and Arcoxia(R)) and they have

Amira Pharmaceuticals Raises $25 Million  -  Mar 23, 2007
American Venture Magazine (press release),...“This is a team who was pivotal in the discovery of three major drugs while previously at Merck & Co (Singulair®, Vioxx®, and Arcoxia®) and they have proved

Keeping kids from losing health care  -  Mar 16, 2007
Providence Business News,...even though Desmarais, who also has asthma, had skimped on her own medication to ensure Danielle got her Advair, Singulair and inhalers.

Merck CEO's compensation: $8 million  -  Mar 13, 2007
Newark Star Ledger,Merck's products include the osteoporosis treatment Fosamax, cholesterol drugs Vytorin and Zetia, and Singulair for asthma and allergies.

Merck's CEO's 2006 pay: $8.04 million  -  Mar 12, 2007
Euro2day,Merck''s products include the osteoporosis treatment Fosamax, cholesterol drugs Vytorin and Zetia, and Singulair for asthma and allergies.

Manhattan Research Reveals Top Consumer-Ranked Pharmaceutical ...  -  Mar 6, 2007
PR Newswire (press release),Pravachol, Prevacid, Protonix, Provigil, Pulmicort, Restasis, Risperdal, Rozerem, Seasonale, Seroquel, Singulair, Sonata, Strattera, Tamiflu, Topamax,

Merck Revises Outlook Upward  -  Feb 28, 2007
New York Times,Merck, which makes the osteoporosis treatment Fosamax and the asthma medication Singulair, also said it expected earnings of $2.55 to $2.65 a share for the

AK Steel announces settlement  -  Feb 28, 2007
Minneapolis Star Tribune (subscription),Merck, the maker of osteoporosis treatment Fosamax and Singulair for asthma and allergies, also said it expects earnings per share of $2.55 to $2.65 for the

New hope for HIV patients from Merck, Pfizer  -  Feb 28, 2007
CNNMoney.com...(a cholesterol-cutting combo produced with Schering-Plough (up $0.20 to $23.56, Charts)), the asthma medication Singulair and newly released products.

New hope for HIV patients from Merck, Pfizer  -  Feb 28, 2007
CNNMoney.com...(a cholesterol-cutting combo produced with Schering-Plough (up $0.23 to $23.59, Charts)), the asthma medication Singulair and newly-released products.

Drug Makes Asthma Easier to Manage  -  Feb 25, 2007
drkoop.comMontelukast, marketed as Singulair in the United States, is commonly used for persistent asthma to prevent asthma flare-ups from occurring.

Pharma Sector: Few Newsmakers Of The Week - Basilea Glaxo ...  -  Feb 25, 2007
Trading Markets,Xolair - administered as a once-a- month injection, and which competes with Merck's Singulair and Glaxo's Advair, will now sport a new alert,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional